GET /api/v0.1/hansard/entries/1494128/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1494128,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1494128/?format=api",
    "text_counter": 565,
    "type": "speech",
    "speaker_name": "Endebess, UDA",
    "speaker_title": "Hon. (Dr) Robert Pukose",
    "speaker": null,
    "content": "and, therefore, the term is to be defined in the proposed Pharmaceutical Practise Bill. In (l), the Farmers and Poisoners Act, Cap 244, provided that a pharmaceutical technologist must be enrolled in the role established under this Act. With regard to the amendment under (m), the term is no longer used in the Bill in line with the proposed amendment of Clause 43(1)(c). In (n), there is no schedule on scheduled substances. The cabinet secretary will publish the list of scheduled substances in the gazette. Under (o), the current definition defines cosmetics in general that are meant to provide the body with the appropriate aesthetics, texture, pH, colour and smell. It is not specific to special cosmetics. In Clause 2(p) of the Bill, we are giving various new definitions which are internationally recognised by the World Health Organisation (WHO). They are critical for the execution of regulatory functions of the Authority, to further identify the Board as used in the Bill, and to provide new definitions for the world's enrolled pharmaceuticals technologists, therapeutic cosmetics, herbal medicine, medical devices and medical substances. The amendment also introduces the definition of the registrar to mean the Director-General of the Authority, as the term is used in various clauses in the Bill. Thank you, Hon. Temporary Chairman."
}